Fonte: Clinical Therapeutics. Unidade: FCF
Assuntos: MEDICAMENTO, NEOPLASIAS DOS GENITAIS FEMININOS, POLIMORFISMO
ABNT
TORSO, Nadine de Godoy et al. Genetic polymorphisms as treatment biomarkers for gynecological malignancies treated with carboplatin and paclitaxel: a systematic review. Clinical Therapeutics, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.clinthera.2025.07.012. Acesso em: 08 out. 2025.APA
Torso, N. de G., Matos, Y. G., Fidelis, G. F. S., Hernandez, C. D., Visacri, M. B., Pincinato, E. de C., et al. (2025). Genetic polymorphisms as treatment biomarkers for gynecological malignancies treated with carboplatin and paclitaxel: a systematic review. Clinical Therapeutics. doi:10.1016/j.clinthera.2025.07.012NLM
Torso N de G, Matos YG, Fidelis GFS, Hernandez CD, Visacri MB, Pincinato E de C, Marzuki JE, Baharuddin B, Santos PCJ de L, Moriel P. Genetic polymorphisms as treatment biomarkers for gynecological malignancies treated with carboplatin and paclitaxel: a systematic review [Internet]. Clinical Therapeutics. 2025 ;[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.clinthera.2025.07.012Vancouver
Torso N de G, Matos YG, Fidelis GFS, Hernandez CD, Visacri MB, Pincinato E de C, Marzuki JE, Baharuddin B, Santos PCJ de L, Moriel P. Genetic polymorphisms as treatment biomarkers for gynecological malignancies treated with carboplatin and paclitaxel: a systematic review [Internet]. Clinical Therapeutics. 2025 ;[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.clinthera.2025.07.012